Galapagos NV (WBO:GLPG) ROE % Adjusted to Book Value : 5.87% (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Galapagos NV ROE % Adjusted to Book Value?

Galapagos NV's ROE % for the quarter that ended in Dec. 2024 was 3.52%. Galapagos NV's PB Ratio for the quarter that ended in Dec. 2024 was 0.60. Galapagos NV's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 5.87%.

Galapagos NV ROE % Adjusted to Book Value Historical Data

The historical data trend for Galapagos NV's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galapagos NV ROE % Adjusted to Book Value Chart

Galapagos NV Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-5.56

-3.24

-7.81

9.15

4.33

Galapagos NV Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															26.75	18.65	2.34	-11.85	5.87

Competitive Comparison of Galapagos NV's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Galapagos NV's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Galapagos NV's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Galapagos NV's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Galapagos NV's ROE % Adjusted to Book Value falls into.

Galapagos NV ROE % Adjusted to Book Value Calculation

Galapagos NV's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	2.60%	/	0.60
	=	4.33%

Galapagos NV's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	3.52%	/	0.60
	=	5.87%

Galapagos NV ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Galapagos NV's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Galapagos NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galapagos NV (WBO:GLPG) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

GLPGF:USA GLPG:USA GLPG:Netherlands GLPGa:UK 0JXZ:UK GXE:Germany G1LP34:Brazil

Address

Generaal De Wittelaan L11 A3, Mechelen, BEL, 2800

Website

https://www.glpg.com

Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.